A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 44,047 shares of BMRN stock, worth $2.83 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
44,047
Previous 52,348 15.86%
Holding current value
$2.83 Million
Previous $4.31 Million 28.15%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$69.02 - $93.84 $572,935 - $778,965
-8,301 Reduced 15.86%
44,047 $3.1 Million
Q2 2024

Aug 14, 2024

BUY
$74.43 - $92.22 $3.9 Million - $4.83 Million
52,348 New
52,348 $4.31 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.9B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.